Cell Signaling Technology

Product Pathways - Translational Control

ATP2A1/SERCA1 (L24) Antibody #4219

Applications Reactivity Sensitivity MW (kDa) Source
W H M R Endogenous 100 Rabbit

Applications Key:  W=Western Blotting
Reactivity Key:  H=Human  M=Mouse  R=Rat
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

Protocols

Specificity / Sensitivity

ATP2A1/SERCA1 (L24) Antibody detects endogenous levels of total ATP2A1/SERCA1 protein.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu24 of human ATP2A1/SERCA1 protein. Antibodies are purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from human skeletal muscle using ATP2A1/SERCA1 (L24) Antibody.

Background

Sarcoplasmic and endoplasmic reticulum Ca2+ ATPases (SERCA) are members of a highly conserved family of Ca2+ pumps (1). SERCA pumps transport Ca2+ from the cytosol to the sarcoplasmic and endoplasmic reticulum lumen against a large concentration gradient (1). ATP2A1 (SERCA1) is a fast-twitch, skeletal muscle sarcoplasmic reticulum Ca2+ ATPase (2). Mutations in the corresponding gene cause an autosomal recessive muscle disorder known as Brody myopathy, which is characterized by muscle cramping and impaired muscle relaxation associated with exercise (1-3).

  1. Hovnanian, A. (2007) Subcell Biochem 45, 337-63.
  2. Odermatt, A. et al. (1996) Nat Genet 14, 191-4.
  3. Odermatt, A. et al. (2000) Hum Genet 106, 482-91.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.

Products